about
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer.Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study.Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary settingMetastases to breast simulating ductal carcinoma in situ: report of two cases and review of the literature.Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.The impact of pregnancy on breast cancer outcomes in women<or=35 years.Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.Lymphoepithelioma-like carcinoma of the breast: report of a case mimicking lymphoma.Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excisionTreatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste.Breast pathology second review identifies clinically significant discrepancies in over 10% of patients.Multicentric mammary carcinoma: evidence of monoclonal proliferation.Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.Expression of c-kit proto-oncogene product in breast tissue.HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.Adjuvant systemic therapy for male breast carcinoma.Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.Inpatient preanalytic process improvements.Pulmonary Mucinous Cystadenocarcinoma Presenting as Extensive Multifocal Cystic Lesions.Histologic localization of sentinel lymph node metastases in breast cancer.Diagnostic pitfalls in fine needle aspiration cytology of atypical apocrine metaplasia in a breast lesion. A case report.Allelic loss on chromosome 22q in epithelioid sarcomas.Adenomyoepithelioma of the breast with associated atypical lobular hyperplasia: a previously unrecognized association with management implications.Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer.Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.Fifteen-Year Journey to High Reliability in Pathology and Laboratory Medicine.A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ.Locoregional Control of Clinically Diagnosed Multifocal or Multicentric Breast Cancer After Neoadjuvant Chemotherapy and Locoregional TherapyAfrican-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapyPleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysisPigmented renal clear cell carcinoma with melanocytic differentiationE-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast
P50
Q30724969-8BFDC48D-4E76-4D13-A4D8-7940F2659C6FQ31135538-6AFD3267-3F06-479B-897C-A886A815FF68Q31156314-A3F1A5FF-DBC3-4222-A080-1529AA748891Q33913513-F5BC49C4-6D3D-4C92-8620-8539DE062E5FQ34137143-108CE603-DFCE-4C51-814C-3FDC9F06A899Q34225755-B9D27C05-D788-4435-BA2B-725F6906FD4EQ34713825-1E55BCE0-C4C6-4685-99B5-C6944FFF3B18Q35042925-1CC03C9F-AE4F-4904-B0C5-42A0EB5F222BQ35068193-DD2F7D47-FC51-4439-85E8-02AADDFA5479Q35193877-29B89DCA-3A1B-4C35-A73E-A325939EB451Q35923368-00DCBA7E-A4CA-47A9-A3D6-8A9CB8859B82Q36162063-EB626C6B-1B3E-4AF9-A329-46054EBB0FB2Q36559394-466F3AD9-9650-4573-A539-5E4A480A5295Q38201649-C1353F58-1676-4BD7-B03E-BA089F465B57Q38255904-B07F643A-17E7-454F-9399-C8FE101538BFQ43947285-2194A31F-7BE5-407F-9C6C-308255FC77CFQ44062327-7303E838-1F94-471C-A8A1-986E983C0E0AQ44968075-7AFF798C-528D-4D87-A249-8AC0E958B59FQ45219353-ED6836B4-01A6-4ACE-AD2D-15341E58E799Q46066014-24345E35-5B0E-453D-9B66-9AB2EF96DE56Q46676464-A1E0B7F4-047B-498D-A7E3-A31FE123C6E5Q46790921-DF1F29DE-47D7-494B-BC16-7BA39F51DC33Q46966638-C26A71D0-67B0-4DE2-AE19-C21DEE88C2E9Q47593035-CB379234-78B9-4684-B145-473E6B6E99D3Q47826051-514AFA14-E337-4C9D-A5B3-AD1132738791Q48233620-B2F1938C-F3BF-4CEE-8A05-0C6EC2F5C6A2Q50495668-90891214-97FC-4B0D-BC56-1861CCCDBEF1Q51042132-8E04E41C-2469-4FE5-B070-818C6F914946Q51096104-23B8D087-9B4A-4C1F-B5C3-CFBCAC3E1CF1Q51272736-CC5E78B1-ACCD-456E-9015-0F3621AF7EF2Q51675519-D9933F0D-377D-44DA-BB79-AFC88C5DA92FQ51800605-A0A94A38-2918-4B9B-92EE-265972449F5AQ51836781-8F2D7699-351C-44FF-BF75-329443B05603Q52364822-780EE9D3-9E52-4E7E-A74B-46FB434FFC35Q52606644-C886FDC3-AD44-4DAB-BA5B-502E0442595CQ63365955-34B6B262-9CBC-46FB-BD8B-3392C644172AQ63366215-4B52335A-8789-4AE4-80A1-D6A41BEC6CB9Q73299094-488A289E-E0A2-4C2A-95B3-6585130657BAQ73568113-706C4116-24D6-40A4-B753-1885DD47D483Q74382652-9B4C598E-6476-4C2E-8E85-EF790BC9D1F8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lavinia P Middleton
@ast
Lavinia P Middleton
@en
Lavinia P Middleton
@es
Lavinia P Middleton
@nl
type
label
Lavinia P Middleton
@ast
Lavinia P Middleton
@en
Lavinia P Middleton
@es
Lavinia P Middleton
@nl
prefLabel
Lavinia P Middleton
@ast
Lavinia P Middleton
@en
Lavinia P Middleton
@es
Lavinia P Middleton
@nl
P106
P1153
7005171424
P31
P496
0000-0001-6445-3947